Pharmacologie des anti-infectieux et antibiorésistance

Recent papers from Pharmacologie des anti-infectieux et antibiorésistance

1. Diagnostic accuracy of prehospital capillary high-sensitivity cardiac troponin I in patients with acute chest pain: the prospective multicenter VALIDATE studyEuropean Journal of Emergency Medicine · 2026
2. URICA Study: Diagnosis and Management of Recurrent Acute Bacterial Cystitis in Women With Urinary Behavioral TherapyInfectious Diseases and Therapy · 2026
3. Diagnostic stewardship as the heart of clinical microbiology: a position paper of the French Society for Microbiology (SFM)Clinical Microbiology and Infection · 2026
4. The bone metastatic niche enhances GJA1-20k expression and mitochondrial remodeling in metastatic prostate cancer cellsBiochemical and Biophysical Research Communications · 2026
5. Creation and validation of a roadside rescue skills scale for training pre-hospital medical teams: the RoadRes-Q scaleScandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2025
6. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trialJournal of Infection · 2024
7. Evaluation of in vitro pharmacodynamic drug interactions of ceftazidime/avibactam and fosfomycin in Escherichia coliJournal of Antimicrobial Chemotherapy · 2023
8. French national epidemiology of bacterial superinfections in ventilator-associated pneumonia in patients infected with COVID-19: the COVAP studyAnnals of Clinical Microbiology and Antimicrobials · 2023
9. PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Pseudomonas aeruginosa Lung Infection.International Journal of Pharmaceutics X · 2023
10. Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., FranceEmerging infectious diseases · 2023
11. Optimized Rhombic Experimental Dynamic Checkerboard Designs to Elucidate Pharmacodynamic Drug Interactions of AntibioticsPharmaceutical Research · 2022
12. Impact of Skin Disinfection on Cutaneous Microbiota, before and after Peripheral Venous Catheter InsertionAntibiotics · 2022
13. Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearanceJournal of Antimicrobial Chemotherapy · 2022
14. Cost-effectiveness analysis of bundled innovative devices versus standard approach in the prevention of unscheduled peripheral venous catheters removal due to complications in FrancePLoS ONE · 2022
15. Efficacy of Three Povidone Iodine Formulations against Cutibacterium acnes Assessed through In Vitro Studies: A Preliminary StudyAntibiotics · 2022
16. PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivoFrontiers in Pharmacology · 2022
17. A physiologically based pharmacokinetic (PBPK) model exploring the blood-milk barrier in lactating species - A case study with oxytetracycline administered to dairy cows and goatsFood and Chemical Toxicology · 2022
18. Ulceroglandular Infection and Bacteremia Caused by Francisella salimarina in Immunocompromised Patient, FranceEmerging infectious diseases · 2022
19. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trialThe Lancet Infectious Diseases · 2021